Study: Only 1 in 7 Colorado Cannabis Products Met State Label Rules
A study reported by StudyFinds found most Colorado cannabis products fell short of key state labeling requirements, reviving questions about how label claims are policed.

A vibrant display of Italian wines, spirits, and gourmet products in a rustic store setting.
The headline number and what it covers
StudyFinds reported that roughly 1 in 7 Colorado cannabis products in the study met key state label rules. That's a failure rate near 86 percent on the requirements the researchers examined.
What CannIntel has in hand is a summary of the research, not the paper itself. It doesn't specify which labeling provisions were tested, how many products were sampled, or whether the products came from licensed retail shelves. Those details determine how far the number travels, and we're not going to guess at them.
Not yet a verdict on the whole market. But a sample this lopsided is hard to wave off.
Why label compliance is a bigger deal than it sounds
A label is the product's legal identity, and in a regulated market it's the first thing an inspector, a plaintiff's attorney, or a consumer reads. Potency declarations, cannabinoid breakdowns, warning language and packaging statements all carry regulatory weight.
For operators, a non-compliant label can mean recalls, administrative penalties, or license exposure. For consumers, a wrong number can mean an unexpected dose. Colorado's regulators, led by the Marijuana Enforcement Division within the Department of Revenue, have long treated labeling as a core compliance function.
The math is hard to argue with. If the study's sample reflects real market conditions, the compliance gap is a business risk, not a paperwork nuisance.
The potency problem sits underneath the label problem
Cannabinoid potency claims are where labeling and chemistry collide, and where the hemp-versus-marijuana debate gets technical fast. A flower label that lists THCA and delta-9 THC separately tells a different story than one reporting total THC, because THCA converts to delta-9 THC when heated through decarboxylation.
Total THC is conventionally calculated as delta-9 THC plus 0.877 times THCA, a factor that accounts for the mass lost when the carboxyl group leaves the molecule. Labs apply that ratio unevenly, and real-world conversion in a pipe or vape rarely reaches the theoretical maximum, so a product can be accurately tested and still be labeled in a way that reads differently to different regulators.
Did the Colorado study count potency formatting as a failure? Nobody outside the research team can say from the summary. Check the underlying paper before assuming.
What this means for Colorado operators
Operators should treat the study as a prompt to audit their own labels against current Colorado rules before regulators or plaintiffs do it for them. Colorado's adult-use market is mature, price-compressed and heavily inspected, which leaves little margin for avoidable penalties.
Multi-state operators face an added wrinkle. A label template that clears review in California, Ohio or Michigan may not satisfy Colorado's specific requirements, and copy-paste compliance is a common failure point in any state.
Small producers are the most exposed. Label review, third-party lab coordination and packaging changes cost real money. Thin-margin shops tend to cut there first.
The regulatory read-through
A published finding that most sampled products miss the mark gives state regulators and legislators a data point to act on, though action isn't guaranteed. Agencies often respond to this kind of research with guidance, targeted sweeps, or rule clarifications rather than immediate enforcement waves.
The study also lands amid nationwide scrutiny of product testing integrity. Lab-shopping and inflated potency numbers have drawn attention in several markets, and label accuracy is the consumer-facing end of that same chain.
This finding isn't a surprise to anyone who has walked a dispensary and read the fine print. The scale is what stands out.
Limits of what we know
The available signal doesn't identify the study's authors, sample size, product categories, or the specific Colorado rules applied. Without those, the one-in-seven figure can't be extrapolated to every product on Colorado shelves.
A narrow sample of, say, edibles tested against packaging rules would tell a different story than a broad sample of flower tested against potency tolerances. Researchers also define compliance differently, and a strict reading can inflate failure rates.
CannIntel will update this story when the underlying paper and any response from the Marijuana Enforcement Division are available. For broader context, see the CannIntel topic hub on cannabis product labeling compliance.
What to watch next
The next signals are the full study text, any MED response, and whether other states with similar rules, including California and Ohio, see comparable research. A regulator statement or a rulemaking notice would turn this from a headline into an operational event.
Hemp-derived and THCA products add another layer, since labeling standards differ for products sold outside the licensed cannabis system. The picture is unsettled. Expect enforcement to vary by jurisdiction and by product type for the foreseeable future.
Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from Laws

Cottage Food Rules Collide With Hemp THC Edibles Boom
A West Central Tribune report on hemp, CBD and THC in cottage foods spotlights a regulatory gap home bakers and state agencies are still trying to close.

FOX8 Maps What Legal Weed Could Look Like in North Carolina
A local TV outlook on adult-use legalization in North Carolina leaves the hard questions, especially hemp and THCA, unanswered.

Utah Opens Comment Window on Medical Cannabis Rules Through Dec. 15
Operators, patients and tax advisers have until December 15 to weigh in on Utah's proposed medical cannabis rules, and the filing details matter more than the headline.
More from the newsroom

Tilray Hits Record Low as Globe and Mail Asks: Buy or Trap?
The Globe and Mail framed Tilray's record-low share price as a buy-or-trap question, and the answer depends on what its operating model actually produces.

The Times Reports Superstrength Cannabis Farms Dot UK Towns
A Times headline says illicit high-potency grows are likely in most British towns, and the economics behind that claim show how an untaxed, unregulated supply chain keeps scaling.

USDA Updates Hemp Crop Insurance for 2027 as THC Risk Looms
The USDA revised hemp crop insurance for the 2027 crop year, and growers are now weighing how the program treats THC compliance losses.